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Abstract
Background: Anxiety symptoms are frequently observed in dental patients, whether they are undergoing simple 
or more invasive procedures such as surgery. This research aimed to compare the effects of Passiflora incarnata 
and midazolam for the control of anxiety in patients undergoing mandibular third molar extraction. 
Material and Methods: Forty volunteers underwent bilateral extraction of their mandibular third molars in a 
randomized, controlled, double-blind, crossover clinical trial. Passiflora incarnata (260 mg) or midazolam (15 
mg) were orally administered 30 minutes before surgery. The anxiety level of participants was evaluated by ques-
tionnaires and measurement of physical parameters, including heart rate (HR), blood pressure (BP), and oxygen 
saturation (SpO2). 
Results: Considering each procedure independently, there were no significant differences between the protocols 
in BP, HR, and SpO2. Over 70% of the volunteers responded that they felt quiet or a little anxious under both 
protocols. With midazolam, 20% of the participants reported amnesia (not remembering anything at all), while 
Passiflora showed little or no ability to interfere with memory formation. 
Conclusions: Passiflora incarnata showed an anxiolytic effect similar to midazolam, and was safe and effective 
for conscious sedation in adult patients who underwent extraction of their mandibular third molars.
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Introduction
Anxiety can be identified in most patients seeking den-
tal care by observing behavior and recognizing physi-
ological signs of anxiety, such as pupil dilation, pallor, 
excessive sweating, increased blood pressure and heart 
rate, tremors, dizziness, dry mouth, weakness, and dif-
ficulty breathing. Dental anxiety, a feeling of anxiety or 
fear at the prospect of dental treatment, is recognized as 
one of the greatest challenges to professional care (1). 
A Brazilian study (2) that assessed the prevalence of 
anxiety during dental treatment using the Dental Anxi-
ety Scale (3) found that 92.4% of subjects had some de-
gree of anxiety. Sedation reduces anxiety, irritability, 
or agitation through the administration of sedatives to 
facilitate planned dental procedures. The goals of seda-
tion are to allow dentists to work effectively and to help 
patients remain as relaxed and comfortable as possible 
(4).
Oral benzodiazepines have a large margin of clinical 
safety and are easy to administer. Despite their low tox-
icity, patients may experience adverse reactions such as 
a rash, nausea, or headache. Benzodiazepines potenti-
ate the effect of ethanol and may promote a paradoxi-
cal reaction. In addition, sedation with benzodiazepines 
requires that patients be accompanied to appointments 
with the recommendation not to operate motor vehicles 
or hazardous machinery for the duration of the drug’s 
pharmacological effects. Among the benzodiazepines, 
midazolam is most commonly used for sedation during 
dental treatments (5-7).
Phytotherapy is among the most popular complementa-
ry therapies, and depression and anxiety are important 
indications for its use. Besides having a lower cost, phy-
totherapy carries a lower risk of collateral effects and 
addiction (8,9). The Passiflora incarnata plant, belong-
ing to the Passifloraceae family and commonly known 
as passion fruit, is widespread in tropical areas around 
the world and used in traditional medicine for the treat-
ment of anxiety, nervousness, and neuralgia (10).
Up to now, only 2 published randomized clinical trials 
(11,12) have reported the anxiolytic effects of preop-
erative Passiflora incarnata. However, neither study 
involved extraction of the third molars. Although Pas-
siflora incarnata is traditionally used as a mild sedative 
and anxiolytic worldwide, there is a paucity of evidence 
from randomized clinical trials to demonstrate this ac-
tivity. Thus, this research aimed to compare the effect 
of Passiflora incarnata with midazolam in the control 
of anxiety in patients undergoing extraction of mandib-
ular third molars.
Material and Methods
The Research Ethics Committee of the Federal Univer-
sity of Sergipe approved this project (protocol number 
06509812.6.0000.0058). The study was designed as a 
controlled, randomized, double-blind, crossover clini-
cal trial. Participants signed an agreement of free and 
informed consent after receiving a detailed explanation 
of the general objectives of the study and their respec-
tive procedures. One researcher collected data between 
November 2012 and September 2013.
Forty volunteer patients from the Department of Den-
tistry, Federal University of Sergipe, were selected after 
diagnosis for bilateral extraction of impacted mandibu-
lar third molars. Volunteers were evaluated for asymp-
tomatic third molars, surgical positions, and similar dif-
ficulties, according to Pell and Gregory’s classification 
system. Exclusion criteria included: age younger than 
18 years; American Society of Anesthesiology (ASA) 
classification III or IV; history of using medicines for 
pain or anxiety in the 15 days before the study; history 
of hypersensitivity to drugs, substances, or materials 
used in this experiment; pregnancy or lactation; and 
history of pericoronitis.
The participants received 15 mg of midazolam (1 pill) 
or 260 mg of Passiflora incarnata (1 pill) administered 
orally 30 minutes before the start of the surgical proce-
dure. In a crossover design, participants were randomly 
assigned an extraction side (right or left) and a protocol 
(midazolam or Passiflora) at the first procedure. The 
researcher delivered the drugs to the participants in en-
coded form as “Protocol 1” (midazolam) or “Protocol 
2” (Passiflora). The protocols were not identified until 
the end of the experiment; therefore, the participants, 
the surgeon, and the statistician were blinded to the 
pharmacological treatments being employed. In order 
to prevent pain and postsurgical edema, a single dose of 
intramuscular dexamethasone (8 mg) was administered 
30 minutes before surgery.
Surgical procedures were performed in 2 sessions, one 
for each side of the mandible. The side to be operated 
on in the first session was randomly selected. A single 
maxillofacial surgeon at the Department of Dentistry, 
Federal University of Sergipe, performed the extrac-
tions. The minimum interval between the first and sec-
ond surgery was 15 days, and the maximum interval 
was 30 days.
The anxiety level of the subjects was assessed in 3 dis-
tinct phases using questionnaires and measurement 
of physical parameters. Phase I (baseline) occurred at 
the initial consultation, one week before the scheduled 
day of the first intervention. The Corah Dental Anxi-
ety Scale (3) was used to classify participants according 
to their degree of anxiety. With the participants resting 
for 5 minutes with their arms positioned at heart level, 
arterial blood pressure (BP) was assessed using a wrist 
monitor (Techline, São Paulo, SP, Brazil). Heart rate 
(HR) and blood oxygen saturation (SpO2) were meas-
ured using a digital pulse oximeter (More Fitness, São 
Paulo, SP, Brazil). All measurements were made by the 
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same researcher and the apparatus was properly cali-
brated. These measurements served as baseline data for 
the physical parameters used to evaluate anxiety.
In Phase II (day of surgery), the investigator and the op-
erator responsible for the surgery assessed the degree 
of anxiety by independently administering the same 
questionnaire to the participant at the end of the surgi-
cal procedure. In addition, the researcher measured BP, 
HR, and SpO2 at the following time points during the 
procedure: 30 minutes after drug administration, ad-
ministration of local anesthesia, incision, extraction of 
the tooth, and suturing.
In Phase III (return visits), sutures were removed and 
volunteers returned on the day after surgery to record 
a self-assessment that asked about the treatment ex-
perience, the occurrence of anterograde amnesia, col-
lateral effects, and surgical preference (first or second 
surgery).
The Mann-Whitney test, Kruskal-Wallis test, multi-
variate analysis of variance (ANOVA), 2-way ANOVA, 
chi-square test, and Fisher exact test were used to per-
form the statistical analysis. A significance level of 5% 
was adopted for all tests. All data were analyzed with 
OriginPro 8.0 SRO software (OriginLab Corporation, 
Northampton, MA, USA).
Results
Twenty-seven out of 40 volunteers (67.5%) were fe-
male, and there were significantly (Fisher exact test, p 
= 0.0398) more women in the sample. However, mean 
age did not differ significantly (Mann-Whitney test, p 
= 0.6302) between men (23.4 ± 5.2 years) and women 
(24.2 ± 4.5 years). 
Table 1 shows the influence of gender on the anxiety 
level of the volunteers. A statistically significant dif-
ference (Mann-Whitney test, p = 0.0090) was observed 
between genders, with women having higher levels of 
anxiety than men.
To understand the effect of age on the degree of anxi-
ety, data were divided into 3 groups. The previously de-
scribed scores were used for comparison of anxiety and 
age. No statistically significant differences (Kruskal-
Wallis, p = 0.0891) were found between ages, indicating 
that age did not influence anxiety levels.
Multivariate ANOVA did not reveal a statistically sig-
nificant difference in systolic BP based on the side of 
the extraction (p = 0.77250) or the order of surgery 
(0.50259), independent of the observation period. Simi-
larly, the operated side and the order of surgery did not 
influence the minimum pressure (side: p = 0.97070; or-
der of surgery: p = 0.27183), HR (side: p = 0.33587; order 
of surgery: p = 0.82525), and SpO2 (side: p = 0.49356; 
order of surgery: p = 0.85607). Thus, in analyzing the 
effect of Protocols 1 and 2, the side of the extraction and 
the order of surgery were not considered. 
Figure 1 shows the influence of both protocols on maxi-
mum and minimum BP. No statistically significant dif-
ference (2-way ANOVA with Holm-Sidak correction for 
multiple comparisons, p = 0.0928) was found between 
the protocols or between the observation periods for 
systolic BP. However, the diastolic pressure showed a 
statistically significant difference (2-way ANOVA, p = 
0.0132), as shown in figure. 1. The minimum values  for 
BP observed during extraction were higher than values 
observed during local anesthesia, incision, and sutur-
ing, but not different from baseline (30 minutes after 
administration) for Protocol 2 (Passiflora). Considering 
only Protocol 1 (midazolam), suturing had lower mini-
mal BP compared to the initial period and extraction. 
There were no statistically significant differences be-
tween protocols (p > 0.05), considering each surgical 
time point independently.
For both protocols, HR increased during extraction and 
remained higher than the initial rate until suturing (Fig. 
2). There were no statistically significant differences 
between the protocols in any of the operative periods.
The SpO2 shown in figure 3 was not significantly differ-
ent (2-way ANOVA, p = 0.0633) between observation 
periods or between protocols.
Were analyzed the results of evaluation of the degree of 
anxiety by the researcher and the operator on the day 
of the procedure. No statistically significant difference 
(chi-square test, p > 0.05) was found between protocols. 
Moreover, no statistically significant difference (chi-
square test, p > 0.05) was found between evaluations 
conducted by the researcher and by the operator.
Table 2 shows the results of self-assessment of anxiety 
level and considers the order in which the operations 
Degree of anxiety
Mildly Low Moderately Extremely Total
Female 1 (3.7%) 10 (37%) 15 (55.6%) 1 (3.7%) 27 (100%)
Male 1 (7.7%) 11 (84.6%) 1 (7.7%) - 13 (100%)
Total 2 (5%) 21 (52.5%) 16 (40%) 1 (2.5%) 40 (100%)
Table 1. Influence of gender on participants’anxiety levels.
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were performed. It was possible to observe an effect of 
Protocol 1 (midazolam) in the second surgery, because 
it increased the proportion of participants who reported 
that they felt quiet. We observed the opposite effect for 
Protocol 2 (Passiflora). In other words, participants who 
underwent the second surgery with Protocol 2 were 
more likely to be anxious. This result may be linked to 
the data in table 3 showing that participants receiving 
Protocol 2 were more likely to remember the surgery.
A significantly greater proportion (Fisher exact test, p < 
0.0001) of participants reported some interference with 
memory for Protocol 1 than for Protocol 2. The results 
showed that Protocol 2 (Passiflora) showed little or no 
ability to interfere with memory formation (Table 3).
Table 4 shows the adverse effects reported by partici-
pants for each protocol. Drowsiness was the most fre-
quently reported effect. There was no statistically sig-
nificant difference (chi-square test, p = 0.0863) between 
the protocols in relation to adverse effects.
Regarding the relative preference of the participants for 
each protocol, twenty-one of 40 subjects (52.5%) pre-
ferred Protocol 1 (midazolam) at either the first or the 
second surgery, whereas 11 participants (27.5%) pre-
ferred Protocol 2 (Passiflora), and 8 participants (20%) 
did not report a preference for either protocol.
Discussion
To compare the anxiolytic activity of Passiflora incar-
nata with midazolam, we opted for an experimental 
model incorporating bilateral extraction of the man-
dibular third molars. Participants served as their own 
controls in this double-blind crossover study.
Anxiety is an inevitable component of oral surgical 
procedures. Sedation is an effective method to reduce 
anxiety, and midazolam is widely used for this purpose 
Fig. 3. Mean (± standard error of the mean) arterial oxygen satura-
tion (SpO2) at each observation period for 2 protocols.
Fig. 1. Mean (± standard error of the mean) systolic and diastolic 
blood pressure at each observation period for 2 protocols. Different 
letters indicate statistically significant differences between observa-
tion periods within the same protocol.
Fig. 2. Mean (± standard error of the mean) heart rate at each obser-
vation period for 2 protocols. Different letters indicate statistically 
significant differences between observation periods within the same 
protocol.
Med Oral Patol Oral Cir Bucal. 2017 Jan 1;22 (1):e95-101.                                                                                                                                                      Passiflora incarnata in control of anxiety
e99
because it provides profound anterograde amnesia and 
satisfactory sedation with minimal changes in the car-
diovascular and respiratory systems. Midazolam has 
become the standard drug because it is an ideal seda-
tive for this type of surgical procedure. Its short action 
is consistent with the average duration of a dental pro-
cedure (5-7,13-18). However, contrary to most authors, 
Zanette et al. (19) concluded in their work that diazepam 
would be better than midazolam in conscious sedation 
dentistry.
In this study, 52.5% of the sample consisted of low-
anxiety individuals, a result similar to that of Campos 
et al. (2) who reported a prevalence of 47.6%. Results of 
this study showed a prevalence of 2.5% for extremely 
anxious individuals, considerably divergent from the 
results of 12.3% reported by Campos et al. (2). 
      Protocol 1 (Midazolam)          Protocol 2 (Passiflora)
How did you feel during the Day surgery? First surgery Second surgery First surgery Second surgery
Quiet 5 (33,3%) 17 (68%) 13 (52%) 3 (20%)
Little anxioous 6 (40%) 7 (28%) 10 (40%) 8 (53,3%)
Very anxious or scared 3 (20%) 1 (4%) 2 (8%) 3 (20%)
So anxious that I felt bad 1 (6,7%) 0 0 1 (6,7%)
Total 15 (100%) 25 (100%) 25 (100%) 15 (100%)
Table 2. Proportion of responses to the question, “How did you feel during the day of surgery?”
Protocol
What do you remember regarding surgery? 1(Midazolam)
2
(Passiflora) Total 
Nothing 8 (20%) 0 8 (10%)
Nearly nothing 3 (7,5%) 0 3 (3,8%)
Some specific fact or event 3 (7,5%) 0 3 (3,8%)
The majority of events 10 (25%) 5 (12,5%) 15 (18,8%)
All 16 (40%) 35 (87,5%) 51 (63,8%)
Total 40 (100%) 40 (100%) 80 (100%)
Table 3. Interference of the drugs with participants’ memories.
Protocol
1
(Midazolam)
2
(Passiflora) Total
Drowsiness 33 (82,5%) 20 (50%) 53 (66,3%)
Muscle relaxation 11 (27,5%) 8 (20%) 19 (23,8%)
Dizziness 7 (17,5%) 2 (5%) 9 (11,3%)
Gastrointestinal problems 1 (2,5%) 0 1 (1,3%)
Allergy 0 1 (2,5%) 1 (1,3%)
Amnesia 1 (2,5%) 0 1 (1,3%)
Epistaxis 0 1 (2,5%) 1 (1,3%)
Insomnia 1 (2,5%) 0 1 (1,3%)
Table 4. Adverse effects reported by participants for each protocol.
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Our results showed that women had higher levels of 
anxiety than men. However, Campos et al. (2) did not 
find a significant association between anxiety and gen-
der, but did corroborate that age did not influence anxi-
ety levels.
No statistically significant difference was found be-
tween the protocols for systolic BP. However, measure-
ment of diastolic pressure showed a significant differ-
ence. Under Protocol 2 (Passiflora), the minimum BP 
values during extraction were higher than those ob-
served during other time points (local anesthesia, inci-
sion, and suturing), but did not differ significantly from 
baseline values. This can be explained by the fact that 
extraction is the most stressful moment during the sur-
gical procedure.
Under Protocol 1 (midazolam), lower diastolic BP val-
ues were noted during suturing than during the initial 
period and extraction. Participants may have felt re-
lieved when the tooth removal was completed and, thus, 
were able to relax more effectively. However, no statisti-
cally significant differences were found between proto-
cols for BP, when each operative period was considered 
independently. This result shows that Passiflora and 
midazolam have similar anxiolytic activity.
Our results showed that HR increased during extraction 
and remained higher than initial levels until suturing for 
both protocols. There were no significant differences 
between the protocols in any of the operative periods, 
showing that the drugs had a similar effect on HR dur-
ing third molar extraction.
Respiratory depression is a common collateral effect of 
benzodiazepines. Various levels of respiratory depres-
sion have been reported, according to the dosage and 
type of sedative medication. Midazolam is accepted as a 
safe sedative agent with a minimal incidence of adverse 
effects. Although this study was not placebo-controlled, 
considering the favorable SpO2 value for a healthy indi-
vidual to be between 99% and 95%, our results showed 
that midazolam and Passiflora did not significantly 
change SpO2 at the doses used in this study. Passiflora 
does not produce respiratory depression, making it safe 
for clinical use. In accordance with our findings, Ustun 
et al. (5) and Fan et al. (17) reported that midazolam 
preserved SpO2 throughout surgery.
Anterograde amnesia (forgetting information that is 
acquired after drug administration) has been demon-
strated following administration of midazolam in sev-
eral studies (5,6,14,20-23). Amnesia seems to be an ad-
vantage for patients who want to avoid the memory of 
an unpleasant experience during dental surgery. In our 
study, 20% of the participants who received midazolam 
reported not remembering anything. However, amnesia 
was not reported by any participant who received Pas-
siflora. Midazolam was associated with a significantly 
higher proportion of patients with altered memory than 
Passiflora. Accordingly, Passiflora showed little or no 
ability to interfere with memory.
Several studies have reported somnolence as a common 
adverse effect of midazolam. In a study by Ritwik et 
al. (18), 66.7% of the subjects showed somnolence after 
oral administratio  n of midazolam. In the present study, 
somnolence was the most commonly reported adverse 
effect for both protocols, reported by 82.5% and 50% 
of participants who received midazolam and Passiflora, 
respectively.
Finally, the participants were asked which surgery felt 
better. Fifty-two percent of participants preferred the 
surgery with midazolam, while 27.5% preferred the 
surgery with Passiflora, and 20% felt there was no dif-
ference between the protocols. The preference for mi-
dazolam can be explained by the fact that this drug has 
the ability to cause anterograde amnesia, resulting in 
participants not remembering what happened in surgery 
and eliminating possible formation of negative memo-
ries of the procedure. Memory interference was the only 
variable resulting in a statistically significant difference 
between the protocols; therefore, it may be the reason 
participants preferred midazolam.
Since this is the first study assessing the anxiolytic ac-
tivity of Passiflora incarnata in surgical dental proce-
dures, it is difficult to discuss the present results in a 
broader context. We believe, however, that Passiflora 
showed anxiolytic activity similar to midazolam, with 
good tolerability, and may constitute an important phar-
macological alternative for the management of anxiety 
during dental treatment.
We concluded from the results of this research that 
Passiflora incarnata has an anxiolytic effect when 
administered in the preoperative oral dose of 260 mg, 
and is safe and effective for conscious sedation in adult 
patients undergoing extraction of the mandibular third 
molars. Comparing the anxiolytic effect of Passiflora 
incarnata (260 mg) with midazolam (15 mg) revealed 
the similarity between the drugs. Participants receiving 
either drug maintained a relatively stable BP and HR, 
with slight variations according to the stages of the sur-
gery, but without exceeding the limits of normality.
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